Archive · 18 Dec 2025
Forbes India Recognizes TMTC as Pioneer in Cross-Border Healthcare
The Medical Travel Company (TMTC) is a new healthcare platform that helps people in the UK get high-quality and affordable medical treatment in India.
They were recently recognized by Forbes India for being one of the top emerging companies with global potential.
TMTC offers a complete solution for medical travel, including doctor oversight, treatment in top hospitals, and aftercare.
They also provide insurance that works in the UK after surgery.
The company was started by Ankit Mehrotra and Sahil Jain in 2024 and has received funding from big investors like Nexus Venture Partners and famous cricketers.
TMTC wants to expand to other countries like the US, Canada, and Europe.
The Medical Travel Company (TMTC) was named to the Forbes India DGEMS 2025 Select 200 list for its innovative approach to cross-border healthcare.
TMTC offers a fully integrated solution for UK patients seeking treatment in India, including clinical oversight, accredited hospitals, and personalized aftercare.
The company was founded in 2024 by Ankit Mehrotra and Sahil Jain and has raised $4.5 million in seed funding from Nexus Venture Partners, 4CAST, and other investors.
TMTC aims to address the gaps in traditional medical tourism by providing seamless continuity of care before, during, and after treatment.
The company plans to expand its operations to other markets such as the US, Canada, Europe, and Australia.
- Who
- The Medical Travel Company (TMTC), founded by Ankit Mehrotra and Sahil Jain
- What
- Recognized by Forbes India DGEMS 2025 Select 200 list for pioneering seamless cross-border healthcare
- When
- December 18, 2024
- Where
- London, UK
- Why
- To address gaps in traditional medical tourism, including fragmented care, hidden costs, and limited post-treatment follow-up
- Company Name
- The Medical Travel Company (TMTC)
- Founders
- Ankit Mehrotra and Sahil Jain
- Year Founded
- 2024
- Funding Amount
- $4.5 million
- Lead Investor
- Nexus Venture Partners
- Other Investors
- Kriscore Capital, 4CAST, Ben Stokes, Jofra Archer, KL Rahul, Sriharsha Majety, Abhishek Goyal, Dr. Ritesh Malik, Manish Vij, Arjun Vaidya
- Target Markets
- UK, US, Canada, Europe, Australia
- Unique Features
- UK-doctor-led clinical oversight, JCI- and NABH-accredited hospitals, 12-month post-surgery insurance valid in the UK, dedicated aftercare center